BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 22314026)

  • 1. Prospective assessment of histological serial sectioning of pelvic lymph nodes in prostate cancer: a cost-benefit analysis.
    Schilling D; Hennenlotter J; Gakis G; Schwentner C; Kuehs U; Stenzl A; Sotlar K
    BJU Int; 2012 Sep; 110(6 Pt B):E166-71. PubMed ID: 22314026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of tumor cell burden by analysis of single cell lymph node disaggregates in metastatic prostate cancer.
    Schilling D; Hennenlotter J; Sotlar K; Kuehs U; Senger E; Nagele U; Boekeler U; Ulmer A; Stenzl A
    Prostate; 2010 Jul; 70(10):1110-8. PubMed ID: 20503396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprostatic lymph node metastasis in prostate cancer and its clinical significance.
    Deng FM; Mendrinos SE; Das K; Melamed J
    Histopathology; 2012 May; 60(6):1004-8. PubMed ID: 22373012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
    Schiavina R; Manferrari F; Garofalo M; Bertaccini A; Vagnoni V; Guidi M; Borghesi M; Baccos A; Morselli-Labate AM; Concetti S; Martorana G
    BJU Int; 2011 Oct; 108(8):1262-8. PubMed ID: 21446934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?
    Gazquez C; Ribal MJ; Marín-Aguilera M; Kayed H; Fernández PL; Mengual L; Alcaraz A
    BJU Int; 2012 Nov; 110(9):1310-6. PubMed ID: 22416928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer.
    Weckermann D; Holl G; Dorn R; Wagner T; Harzmann R
    BJU Int; 2007 May; 99(5):1036-40. PubMed ID: 17437437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
    Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
    Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological step sectioning of pelvic lymph nodes increases the number of identified lymph node metastases.
    Engvad B; Poulsen MH; Staun PW; Walter S; Marcussen N
    Virchows Arch; 2014 Jan; 464(1):45-52. PubMed ID: 24259030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodal occult metastases in intermediate- and high-risk prostate cancer patients detected using serial section, immunohistochemistry, and real-time reverse transcriptase polymerase chain reaction: prospective evaluation with matched-pair analysis.
    Schiavina R; Capizzi E; Borghesi M; Vagnoni V; Romagnoli D; Rocca GC; Giunchi F; D'Errico A; De Giovanni A; Rizzi S; Brunocilla E; Martorana G; Fiorentino M
    Clin Genitourin Cancer; 2015 Apr; 13(2):e55-64. PubMed ID: 25212578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
    Budiharto T; Joniau S; Lerut E; Van den Bergh L; Mottaghy F; Deroose CM; Oyen R; Ameye F; Bogaerts K; Haustermans K; Van Poppel H
    Eur Urol; 2011 Jul; 60(1):125-30. PubMed ID: 21292388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
    BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node counts in endometrial cancer: expectations versus reality.
    Euscher ED; Bassett R; Malpica A
    Am J Surg Pathol; 2011 Jun; 35(6):913-8. PubMed ID: 21566518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size and volume of metastatic and non-metastatic lymph nodes in pelvis and lower abdomen in patients with carcinoma of the bladder undergoing radical cystectomy.
    Jensen JB; Ulhøi BP; Jensen KM
    Scand J Urol Nephrol; 2010 Nov; 44(5):291-7. PubMed ID: 20446823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach.
    Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R
    Ann Surg; 2009 Apr; 249(4):602-7. PubMed ID: 19300229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
    Schiavina R; Borghesi M; Brunocilla E; Manferrari F; Fiorentino M; Vagnoni V; Baccos A; Pultrone CV; Rocca GC; Rizzi S; Martorana G
    BJU Int; 2013 Jun; 111(8):1237-44. PubMed ID: 23331345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological detection of minimal metastatic disease in inguinal non-sentinel lymph nodes in penile cancer.
    Naumann CM; Macquarrie A; Van Der Horst C; Hamann MF; Al-Najar A; Kaufmann S; Hegele A; Korda JB; Bolenz C; Jochens A; Jünemann KP; Leuschner I
    Anticancer Res; 2010 Feb; 30(2):467-71. PubMed ID: 20332456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
    Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
    Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.